Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography
- PMID: 22872314
- DOI: 10.1161/CIRCULATIONAHA.112.110031
Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography
Erratum in
- Circulation. 2014 Apr 1;129(13):e429
Abstract
Background: The addition of myocardial perfusion (MP) imaging during dipyridamole real-time contrast echocardiography improves the sensitivity to detect coronary artery disease, but its prognostic value to predict hard cardiac events in large numbers of patients with known or suspected coronary artery disease remains unknown.
Methods and results: We studied 1252 patients with the use of dipyridamole real-time contrast echocardiography and followed them for a median of 25 months. The prognostic value of MP imaging regarding death and nonfatal myocardial infarction was determined and related to wall motion (WM), clinical risk factors, and rest ejection fraction by the use of Cox proportional-hazards models, C index, and risk reclassification analysis. A total of 59 hard events (4.7%) occurred during the follow-up (24 deaths, 35 myocardial infarctions). The 2-year event-free survival was 97.9% in patients with normal MP and WM, 91.9% with isolated reversible MP defects but normal WM, and 67.4% with both reversible MP and WM abnormalities (P<0.001). By multivariate analysis the independent predictors of events were age (hazard ratio 1.05, 95% confidence interval [CI], 1.02-1.08), sex (hazard ratio, 2.36; 95% CI, 1.32-4.23), reversible MP defects (hazard ratio, 3.88; 95% CI, 1.83-8.21), and reversible WM abnormalities with reversible MP defects (hazard ratio, 4.51; 95% CI, 2.25-9.07). Reversible MP defects added incremental predictive value and reclassification benefit over WM response and clinical factors (P=0.001).
Conclusions: MP imaging using real-time perfusion echocardiography during dipyridamole real-time contrast echocardiography provides independent, incremental prognostic information regarding hard cardiac events in patients with known or suspected coronary artery disease. Patients with normal MP responses have better outcome than patients with normal WM; patients with both reversible WM and MP abnormalities have the worst outcome.
Comment in
-
Myocardial contrast echocardiography for simultaneous assessment of function and perfusion in real time: a technique comes of age.Circulation. 2012 Sep 4;126(10):1182-4. doi: 10.1161/CIRCULATIONAHA.112.129031. Epub 2012 Aug 7. Circulation. 2012. PMID: 22872313 No abstract available.
Similar articles
-
Effect of Coronary Revascularization on the Prognostic Value of Stress Myocardial Contrast Wall Motion and Perfusion Imaging.J Am Heart Assoc. 2017 May 31;6(6):e006202. doi: 10.1161/JAHA.117.006202. J Am Heart Assoc. 2017. PMID: 28566297 Free PMC article.
-
Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography.JACC Cardiovasc Imaging. 2013 Jan;6(1):1-12. doi: 10.1016/j.jcmg.2012.08.009. Epub 2012 Dec 5. JACC Cardiovasc Imaging. 2013. PMID: 23219414
-
Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography.Circulation. 2005 Sep 6;112(10):1444-50. doi: 10.1161/CIRCULATIONAHA.105.537134. Epub 2005 Aug 29. Circulation. 2005. PMID: 16129798
-
The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis.Circ Cardiovasc Imaging. 2013 Jul;6(4):574-82. doi: 10.1161/CIRCIMAGING.113.000035. Epub 2013 Jun 14. Circ Cardiovasc Imaging. 2013. PMID: 23771988 Review.
-
Prognostic Value of Myocardial Perfusion Analysis in Patients with Coronary Artery Disease: A Meta-Analysis.J Am Soc Echocardiogr. 2017 Mar;30(3):270-281. doi: 10.1016/j.echo.2016.11.015. Epub 2016 Dec 31. J Am Soc Echocardiogr. 2017. PMID: 28049598 Review.
Cited by
-
The clinical use of stress echocardiography in ischemic heart disease.Cardiovasc Ultrasound. 2017 Mar 21;15(1):7. doi: 10.1186/s12947-017-0099-2. Cardiovasc Ultrasound. 2017. PMID: 28327159 Free PMC article. Review.
-
Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia.Nat Rev Cardiol. 2020 Jul;17(7):427-450. doi: 10.1038/s41569-020-0341-8. Epub 2020 Feb 24. Nat Rev Cardiol. 2020. PMID: 32094693 Free PMC article.
-
Stress Echocardiography in Stable Coronary Artery Disease.Curr Cardiol Rep. 2017 Oct 18;19(12):121. doi: 10.1007/s11886-017-0935-x. Curr Cardiol Rep. 2017. PMID: 29046974 Review.
-
Recent technological advancements in cardiac ultrasound imaging.Ultrasonics. 2018 Mar;84:329-340. doi: 10.1016/j.ultras.2017.11.013. Epub 2017 Nov 23. Ultrasonics. 2018. PMID: 29223692 Free PMC article. Review.
-
Standard echocardiography versus very-low mechanical index contrast-imaging: left ventricle volumes and ejection fraction multi-reader variability and reference values in a subgroup with no risk factors or cardiac disease.Heart Vessels. 2020 Apr;35(4):544-554. doi: 10.1007/s00380-019-01506-x. Epub 2019 Sep 17. Heart Vessels. 2020. PMID: 31531717
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical